agilon health, inc.
AGL
$2.96
$0.0652.25%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 23.09% | 40.40% | 54.06% | 65.46% | 74.31% |
| Total Other Revenue | 14.39% | 42.18% | 75.07% | 176.95% | 213.51% |
| Total Revenue | 23.07% | 40.41% | 54.10% | 65.62% | 74.48% |
| Cost of Revenue | 25.31% | 42.60% | 63.34% | 72.90% | 81.14% |
| Gross Profit | -127.26% | -93.05% | -129.82% | -69.74% | -49.56% |
| SG&A Expenses | -11.81% | -7.44% | -5.55% | 5.74% | 22.50% |
| Depreciation & Amortization | 34.66% | 52.48% | 118.48% | 110.51% | 121.96% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 23.24% | 39.49% | 58.26% | 67.63% | 76.46% |
| Operating Income | -26.74% | -22.42% | -182.30% | -125.12% | -129.82% |
| Income Before Tax | -27.11% | -27.96% | -353.96% | -176.75% | -140.03% |
| Income Tax Expenses | -26.35% | 83.44% | -103.56% | 295.73% | 5,135.42% |
| Earnings from Continuing Operations | -26.47% | -28.18% | -346.76% | -177.42% | -143.07% |
| Earnings from Discontinued Operations | 116.24% | 85.46% | -283.24% | -716.54% | -823.00% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -117.54% | -124.15% | -99.58% | -81.75% | -61.87% |
| Net Income | 15.00% | 0.93% | -334.16% | -239.87% | -210.24% |
| EBIT | -26.74% | -22.42% | -182.30% | -125.12% | -129.82% |
| EBITDA | -25.35% | -20.19% | -188.26% | -126.52% | -134.89% |
| EPS Basic | 16.03% | 2.24% | -333.15% | -241.94% | -211.80% |
| Normalized Basic EPS | -24.04% | -22.45% | -349.86% | -178.32% | -160.14% |
| EPS Diluted | 15.75% | 2.81% | -314.71% | -235.98% | -208.81% |
| Normalized Diluted EPS | -24.04% | -22.29% | -348.13% | -177.37% | -159.25% |
| Average Basic Shares Outstanding | 1.00% | 0.50% | 0.05% | -0.62% | -0.50% |
| Average Diluted Shares Outstanding | 1.00% | -0.32% | -0.76% | -1.43% | -1.31% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |